text:
2009 MotoGP Misano Race Report - Making A Point
Submitted by David Emmett on Tue, 2009-09-08 13:16
On the face of it, MotoGP is in trouble. There are just 17 bikes on the grid, the lowest number in recent memory; a factory has withdrawn due to financial problems, as has a satellite team; another team has had to swap riders mid-season to bring in someone with sufficient sponsorship to allow the team to continue. Every couple of races MotoGP's rule-making body meets, trying to find new ways to cut costs and looking for rule changes that might make the series cheaper. And contract negotiations have switched from being about riders extracting large salaries from the teams that are trying to hire them to teams finding the riders who will ride for free and bring in the most sponsorship cash.
Yet take a step back and throw off the shroud the global recession has cast over the MotoGP paddock and the series is looking as healthy as ever. Sure, there may be only 17 bikes on the grid, but there are four riders who are capable of winning at any racetrack we visit. The margin of victory is falling again and last-lap passes and gaps of under a second are becoming the norm rather than the exception. Crowd attendance is up, as are TV audiences; team merchandise sales are extremely brisk; and new outside industry sponsors are trickling into the sport, finding valuable opportunities to promote their brands.
Best of all, perhaps the greatest rider of all time is up against a young apprentice, a rider whose speed matches his and who is learning the master's tricks at incredible speed. Both men have an insatiable appetite for victory, a keen intelligence, and otherworldly levels of ability. What's more, both Valentino Rossi and Jorge Lorenzo are on exactly the same bike - though Lorenzo might occasionally dispute that assertion.
Injury and illness have kept Dani Pedrosa and Casey Stoner from interfering too much in this rivalry - Pedrosa and Honda's progress delayed by the Spaniard's leg injury suffered during the preseason testing, and Stoner and Ducati's fierce challenge blunted by the Australian's mystery illness and his absence from the last three races - but that has only served to make the match up between team mates all the more intense. After two costly mistakes by Jorge Lorenzo gave Rossi the upper hand in the title race, a similarly expensive error at Indianapolis by The Doctor handed back half his championship lead and gave Lorenzo hope of the title once again.
Little Donkey
So elementary was Rossi's mistake that he turned up at Misano with a special helmet, one similar to his Mugello "scream" helmet, but with a picture of Donkey, the character from Shrek, painted in where his face was at Mugello. Because the first thing that went through his mind as he slid through the grass at Indy, Rossi told reporters, was that he felt exactly like a donkey for being so incredibly stupid.
The custom helmet announced to the world, but most especially to Valentino Rossi, that he had a special mission to fulfill here at Misano. The circuit is in Rossi's back yard, literally just half a day's walk from the hillside village where the Italian legend lives, and from the moment Rossi hit on Friday it was clear that he meant business. His team mate put in deeply impressive runs during practice, with many laps inside the existing lap record, but at the end of each session The Doctor would pull out a few super-fast laps and it would be Rossi's name at the top of the timesheets, not Lorenzo's. The way that Rossi pushed, it was clear that this was personal and purposeful. Rossi was claiming his home ground.
Qualifying was a case in point. With less than a minute left in the session, Jorge Lorenzo seemed to have pole position in the bag, topping the timesheets with a 1'34.808. But with just seconds to go, Valentino Rossi crossed the line to take one last shot, the track clearing ahead of him like the Red Sea, Rossi steaming to a lap nearly half a second quicker than his Fiat Yamaha team mate. His point had been forcefully made.
As the bikes lined up on the grid, Jorge Lorenzo knew all too well the disadvantage he faced. The Spaniard had failed to find the extra speed he needed during the morning warm up, finishing the session shaking his head ominously. And he had Dani Pedrosa between himself and Rossi on the front row, a lightning-fast starter, and certain to get in his way at the start and prevent him from putting space between himself and Rossi.
Human Torpedo
Just as Lorenzo had feared, it was Dani Pedrosa who led off the line when the lights dimmed. The Repsol Honda rider repeated his usual trick, using his light weight and the Honda's launch control to maximum effect. Another Honda led the screeching pack that chased Pedrosa down towards Turn 1, Toni Elias leaping past the marginally slower Yamahas of Valentino Rossi and Jorge Lorenzo to take 2nd, while Colin Edwards completed the trio of chasing M1s, his Monster Tech 3 bike right on the tail of Lorenzo's factory Fiat Yamaha.
But Misano's first corner complex is notorious, the right-left combination highly successful at collecting the over-eager and dumping them in the gravel traps, and with so many Italians riding in front of their home crowd, the over-eager were well represented. This year, it was the turn of Alex de Angelis to get into Turn 2 too hot, running round the outside of Turn 1 in an attempt to stay with the leaders before they could make a break. Exiting Turn 1, De Angelis flicked the bike left again but was going too fast to get the machine turned, spearing Colin Edwards amidships and skittling Nicky Hayden in the process, the Marlboro Ducati man making a strong run round the outside of Turn 2 and ready to chase the leaders.
Hayden was incandescent with rage, almost as angry as he had been after Dani Pedrosa had taken him out at Estoril in 2006. There was much less at stake at Misano in 2009, but Hayden was just starting to find a rhythm with the Ducati that he had taken so long to tame, and had been looking forward to the race. Edwards was more phlegmatic about the affair, telling the BBC afterwards "We're in Italy, you always have to keep a lookout for dumbass Italians."
De Angelis himself was probably the chief victim of the incident. The man from San Marino, the tiny mountain kingdom just a few miles away, had been widely tipped to take a ride at the Pramac Ducati squad next season. All of Ducati's top brass were present at Misano and none were particularly impressed by the Italian's impetuosity, and so De Angelis torpedoed not just Edwards and Hayden, but also perhaps his best chance of staying in MotoGP next season.
Innocent Bystanders
There were more that suffered: Everyone in mid-pack got held up a little, and Randy de Puniet, a man who has yet to complete a race lap at Misano having crashed out of the two previous editions, found himself sitting in a Misano gravel trap once again. This year, though, his luck had changed, and still upright he rode through the gravel and back onto the track, 10 seconds down but still moving.
The crash had even seen a stray bike tag the back of Jorge Lorenzo's machine, but the force of the collision was slight enough for the Spaniard to stay on the bike without losing too much time on Rossi. Head down, he chased his team mate and was soon right on the back of Rossi once again.
At the front, Dani Pedrosa was trying to escape, but that was a tougher task than usual. The job was complicated by Toni Elias, the Spaniard determined to prove that he should not be out of a ride next season, and pushing his compatriot hard. Elias chased the Repsol Honda down along the back straight, closing through the terrifying right flick of Curvone, and preparing to attack as the track tightened up for the Carro complex. Now close enough he made his move, but his eagerness betrayed him. Pedrosa had been expecting the Gresini Honda rider and he let Elias run out wide, passing him back immediately on the tighter line.
As they crossed the line for the first time, Jorge Lorenzo initiated his first attack on his team mate. With drive from the final corner, Lorenzo was across the line and into Turn 1 ahead of Rossi. But only just: Rossi's parry saw him almost hit the back of Lorenzo's bike as they flicked back left for Turn 2, The Doctor only just pulling up in time.
Neither Elias nor Rossi were going to settle for the places they were in. The four men ran together, Pedrosa leading ahead of Elias, while Lorenzo chased his two countrymen, hounded from behind by Rossi. Elias was the first to make a move, pulling an audacious move round the outside of Pedrosa at Quercia on lap 3. Seeing a clear breach of his "Porfuera" copyright, Lorenzo tried putting Elias in his place, attacking into the tightening rights that follow the Curvone. Foiled, Lorenzo looked again, this time into the corner leading onto the back of the paddock straight, but Elias countered once again, making his RC212V as wide as possible.
Forging Ahead
Rossi took advantage of Lorenzo travails, the Spaniard distracted by his attacks on the Gresini Honda, and The Doctor slid past his team mate heading into Turn 1 to start lap 5. Now Rossi had Elias to deal with, and the Italian did so briskly, diving inside of Elias through Turn 6 and holding off the Spaniard into Quercia. Seeing Rossi pass Elias spurred Lorenzo into action, and the Mallorcan dropped any coyness he may still have had, squeezing past the Gresini Honda through the tight right hander at Carro and taking over 3rd.
The scrap at the front had been tight enough to hold the leaders up, and Andrea Dovizioso, running for the first time on Ohlins suspension, took advantage. The Italian had been unaffected by the first corner pile up, and had dispatched Loris Capirossi the following lap to give chase to the leaders. By lap 5 he was on the back of Lorenzo, but after the factory Yamaha rider got past Elias, Dovizioso faced the same challenge that both Rossi and Lorenzo had, attempting to get by the wide-as-a-truck Gresini Honda. It only took a lap or so, but by the time Dovi succeeded, there was clear space between himself and the front three and a gap too large to bridge.
For Rossi, the math was simple: Two Spaniards down, one more to go. But Dani Pedrosa, still leading the race, was even tougher to pass than his fellow countryman Elias had been. Rossi poked and probed, but every time he did, he left himself open to attack from behind, and Lorenzo would not let him forget it.
But Rossi was on a mission, and would not be denied. It took him three laps, but eventually, he got past Pedrosa through the right handers curling back towards the back straight. Past but not away, the two Spaniards he had overtaken were still sticking to his tail. At first, when Rossi pushed, Pedrosa and Lorenzo responded, the gap never growing. On lap 11, Rossi pushed again and this time he got a gap, Pedrosa being more engaged in holding off the attentions of Lorenzo than in chasing down the man in front.
Stuck In Traffic
This left Lorenzo frustrated. Pedrosa was capable of getting close to Rossi's pace, but the Spaniard was not capable of matching or even bettering it, and clear blue air was starting to open between the Repsol Honda and the #46 Yamaha. If Lorenzo was to keep his title hopes alive, recently resuscitated by Rossi's crash at Indianapolis, he could barely afford to lose 5 points to The Doctor, let alone 9, the difference between 1st and 3rd. Lorenzo knew what he had to do, but Pedrosa was putting up more resistance to his arch rival than he had to Rossi.
Lorenzo would get by but it would take him 6 costly laps. The pressure he had been applying to Pedrosa eventually became too much for the Repsol Honda man, Pedrosa running into Quercia too hot and going wide, the door finally open for Lorenzo to get through. Lorenzo did not need a second invitation, and was off to chase down Rossi, the gap now nearly a second and a half.
On his first clear lap Lorenzo took back a tenth, but Rossi had seen his pit board, and had stepped up the pace once again. Lorenzo, too, was back in the groove, but in front of his home crowd, Rossi's rhythm resounded to a faster beat and the Italian edged away, tantalizingly out of reach and receding, too far and too fast for Lorenzo to catch.
For the final third of the race, Rossi blazed a trail of glory through the Italian hillsides, untouchable by any who dared to challenge him. For the second year in succession, Valentino Rossi took a significant win at Misano, cementing his hold on the championship and bringing him yet another step closer to usurping Giacomo Agostini's place in the record books. Misano was Rossi's 103rd win, with 19 - or 20, depending on how you count them - to go to match Agostini, and scored another 25 points towards his 7th MotoGP title.
Jorge Lorenzo had been forced to yield to Rossi's superior pace, held up in the early laps enough that he was unable to challenge his Fiat Yamaha team mate for victory. Yet even if Lorenzo had not been held up, he would have had his hands full with The Doctor. When Rossi arrives at a racetrack where he feels he has a point to prove, he is almost impossible to beat. Lorenzo had been fast all weekend, but not fast enough and Sunday was no exception.
Once the two Fiat Yamaha's had got past Dani Pedrosa, they had immediately disappeared. Pedrosa was starting to lose grip, both on corner entry and corner exit, and the Yamahas were lapping first half a second, then a whole second a lap faster than Pedrosa's Honda. Pedrosa was forced to settle for 3rd, the position he had been saying all weekend he expected to be. Before the race on Sunday, Honda announced that they had finalized the contracts with Dovizioso and Pedrosa but the Spaniard had only signed up for a single year. The man who Honda has brought up through the ranks is growing increasingly disillusioned with Big Red, and unless they deliver on the promise of a much improved bike, 2010 could well be Pedrosa's last season for Honda.
The pair of Fiat Yamahas were followed by a pair of Repsol Hondas, but Andrea Dovizioso had been forced to fight for his 4th place. After losing touch with the front three Dovi had fallen back into the clutches of a resurgent Loris Capirossi. The Suzuki man had even passed Dovizioso with 3 laps to go, and the Repsol Honda rider had to wait until the final run into Quercia at the end of the back straight to take back 4th from Capirex. But for a first outing on Ohlins suspension, 4th place is a pretty good start.
Dovi's pass left Loris Capirossi with no option but to grudgingly settle for 5th. Yet the Italian veteran leaves Misano with some hope, as the upgrades which the Suzuki has received recently seem finally to be paying off and the bike could start to be competitive again before the end of the season.
Toni Elias, who had started the race so well, eventually came home in 6th after following Dovizioso and Capirossi fighting over 4th. He had been unable to get involved but still posted a decent result, especially for a rider who will be without a seat in MotoGP next season.
A couple of seconds behind Elias, Mika Kallio scored his best result of the season on what will presumably be his final ride on the factory Ducati, filling in for the absent and sorely missed Casey Stoner. Kallio had been made to fight for 7th by Marco Melandri, but in the end the Ducati prevailed over Melandri's ailing Hayate.
Chris Vermeulen had had a strong start, but got caught up in the melee in the first corner. The Australian made up a couple of places before the end of the race, posting respectable lap times, but once again, Vermeulen could manage only a 9th place finish. The Australian has spoken often of his desire to stay in MotoGP, but he will need better results if he is to find a new home now that he has lost his Rizla Suzuki seat to Alvaro Bautista for next year.
Vermeulen finished ahead of another rider in the danger zone, Britain's James Toseland on the Monster Tech 3 Yamaha. Toseland still doesn't have a contract for next season, and though it is known that Dorna is keen to keep a British rider in the series, another 10th place finish is hardly a convincing reason for him to stay. Toseland has never really got to grips with the Bridgestone spec tires, and this looks like being his downfall this season.
Though 10th is hardly impressive for Toseland, Aleix Espargaro's 11th place finish on just his second ride on the satellite Pramac Ducati turned an awful lot of heads. Espargaro posted the 5th fastest lap time during the race, and the speed with which he has learned to ride the MotoGP bike may have earned him a place for the rest of the season, replacing his temporary team mate Niccolo Canepa, who has failed to impress this year.
Randy de Puniet was hardly pleased to have come home in 12th, but at least he finally got to complete a race lap of Misano. Some 14 seconds back at the end of the first lap, he reeled in the men ahead of him, coming up just 5 seconds short of 11th spot. De Puniet's race may have been long and lonely, but at least he finally got to finish at the Adriatic circuit.
Bringing up the rear of the field were once again MotoGP's weakest links. Niccolo Canepa was not as far off the pace at Misano, a track he knows the layout of, but he still finished in 13th. Meanwhile, Gabor Talmacsi is still half a second a lap slower than Canepa and a second a lap slower than the rest, a second he needs to find soon if he is to be competitive. The Hungarian oil giant sponsoring Talmacsi may be pleased with a high-profile rider like Talmacsi, but you have to wonder if they'll agree to keep paying the significant sums involved just to see the Hungarian running around at the back of the field.
Things Are Looking Up
There may only have been 14 finishers at Misano, but the celebrations at the end of the road swept any worries about the future of the sport from everyone's minds. Valentino Rossi had come to his local track with a mission: To make amends for his stupidity at Indianapolis, as the donkey helmet and post-race donkey ears were meant to remind everyone. But there was an unspoken message underlying that mission as well. After giving away his advantage over his team mate through an act of temporary madness, he had to stamp his authority back on the championship, on the team, and on his team mate. The way he achieved all these goals was intimidating, exactly as he had intended it to be.
With Valentino Rossi in the championship, and being pushed harder than ever by some of the most talented young racers to appear on the scene in a generation, the future for MotoGP is looking bright. And with a host of fresh young faces expected to arrive next season, and rumors of more bikes to appear on the grid, the future could be brighter than anyone expects. The 2009 MotoGP season got off to a tough start, but since the bleak winter of '08 and '09 things have kept on getting better.
round_number:
race_result:
2009 Misano MotoGP Race Result - A Blow Struck In Title Race
2009 MotoGP World Championship Standings After Round 13, Misano, San Marino
Misano, Italy
Mugello scream helmet
phoenix1 replied on Tue, 2009-09-08 15:26
The scream helmet was Mugello.
And as for the state of racing, I'm not settling for flank steak. We used to be treated to motorsports filet mignon until the MSMA lost touch with reality and started making poor technical decisions. I'm not settling for the motorsports masquerade we have now.
Otherwise, a great read. :)
Rusty Bucket USA replied on Wed, 2009-09-09 01:48
OK, it is fixed. Thank you for pointing that out.
I should have noticed that, myself, but... Misano, Mugello, Monza... it's easy to overlook. ;-)
"PERHAPS the greatest rider of all time"
steve1974 replied on Tue, 2009-09-08 18:48
Im glad you wrote perhaps. I guess for some people It may come as a surprise that there was motorcycle racing before Rossi.
Apparently, there was a racer called Mick Doohan, who won 5 titles in a row and within that period with a winning percentage of 62%. Identical to Rossi's first 5 titles; and briefly, against the same opposition.
Lets not forget the NSR was
krka1073 replied on Tue, 2009-09-08 19:26
Lets not forget the NSR was head and shoulders above the field for the most part during his rein.
Until this year, the Yamaha was most certainly not...
Mick..
peteboy replied on Wed, 2009-09-09 06:52
Yes. What was Mick doing in those years actually brought me to this sport and made me believer. And those days i've noticed young bloke from 125s and something special about him was aparrent from the beginning. This guy was supposed to make extrordinary things in years to come it was VR of course. I loved Mick and some others too. I fully appreciate their class. But for me, considering his career sofar VR IS "da greatest".
Grand Prix Commission Scraps MotoGP Penalty Point System
Mika Kallio Replaces Johann Zarco In Factory KTM Team For Rest Of 2019 Season
2011 Catalunya MotoGP Qualifying Practice Result: Unexpected Polesitter Takes Tight Pole


For the past decade I have been privileged to follow in my esteemed father-in-law's footprints and edit this unique quarterly book review journal. It has been an enjoyable and rewarding experience. As you, our loyal readers know, the last two years have been irregular ones for the Bookman. The primary reason has been financial. The costs of producing this quarterly have exceeded the income generated from subscriptions for some years now. We simply came to the point where we had to suspend publication until we could find a financial solution to this problem. Thankfully, the Earhart Foundation of Ann Arbor, Michigan, came to our rescue with a grant that allows us to resume a regular publication schedule (and indeed to catch up on some missing numbers) for the near future. I personally apologize to our subscribers for the lack of communication in recent months and any confusion about your subscription status. We are busily trying to right the Bookman ship and you recently should have received a letter informing you about your subscription extension and offering you a book voucher as a token of our gratitude to you for your goodwill and patience.
Moreover, during the course of working to revive the journal I decided it was time for me to step aside and inject some new blood and energy into the publication. My schedule and competing priorities make it difficult for me to keep up with the demands of the journal. Though it was a difficult decision personally, it was made easier by the fact that my successor is an able editor, friend, and frequent contributor to the Bookman—Mr. Gerald J. Russello. Many of you will be familiar with Gerald's writings, both in this journal and in many others, and no doubt will come to sharemy enthusiasm for this appointment. Gerald is a practicing attorney and will bring the combination of scholarly rigor and an appreciation for our principal audience—the common reader—to his editorial duties. As a former Kirk Center Wilbur Fellow, Gerald has the right credentials regarding the founder of this little quarterly.
Gerald received his undergraduate degree in Classics from Georgetown University, and his law degree from New York University School of Law. Following law school, he clerked for two appellate judges and is now in government practice after several years at a prestigious New York City firm. Gerald edited a fine collection of Christopher Dawson's writings for the Catholic University of America Press and currently has a book on the thought of Russell Kirk under serious consideration at the University of Missouri Press. In addition, Gerald is a Fellow of the Chesterton Institute at Seton Hall University, and his essays and reviews have appeared in The Wilson Quarterly, the Chesterton Review, The Wall Street Journal, National Review, Commonweal, First Things, The New Criterion, Modern Age, Touchstone, as well as several law reviews and edited collections. He lives in Brooklyn with his wife and two daughters. Welcome aboard Gerald, defender of the Permanent Things!
As for me, I will continue to be involved in the Bookman, but am kicking myself upstairs. I will co-publish the Bookman with my mother-in-law, Annette Kirk. Together, we will focus on getting the Bookman on solid financial ground. Our very able and indispensable managing editor, Claudia Henrie, will remain in her current position—a great boon to us all, especially to Gerald.
Finally, on a sad note, as we welcome Gerald we also say goodbye to two long-time supporters of this publication. Dr. Regis Courtemanche was a member of the board of The Educational Reviewer (the publisher of the Bookman) for many years. Regis was a dedicated teacher of history to some 17,000 students over a period of thirty-six years at C. W. Post College. His book, No Need for Glory, published by Annapolis Navel Institute was a study of Britain's near entry into the American Civil War. Regis will be remembered for his great wit, amusing anecdotes, and deep dedication to his students and family.
Mr. Charles Teetor, the husband of the vice president of The Educational Reviewer, Mickie Teetor, was an avid sailor who often participated in the Bermuda races. He was the author of Strolling Through Barcelona and of Charley Teetor's Hometown. Chuck will be especially remembered for his wonderful rendition of the flamenco on his Spanish guitar and as a storyteller of great charm. He was also a great book man and family man.
Chuck and Regis, along with the founding editor of this quarterly, Russell Kirk, sailed the Atlantic together. As all have now crossed over the bar, we pray that they are enjoying their heavenly state, sailing with the angels in each other's company.


Imagine just hanging out on a Caribbean Island with nothing to do and all ambition fast evaporating in the trade winds. That's just what Paul and Elizabeth did one day on Half Moon Cay. There is soft white sand to enjoy, incredible blue green waters to swim in and plenty of just plain quiet. Makes for a perfect day. Join Paul and Elizabeth on a perfect day in the Caribbean. While Holland America Line is committed to keeping 98 percent of its pristine private island wild, Half Moon Cay offers everything you need for a day of play on your Caribbean cruise. Park yourself in an air-conditioned cabana along a two-mile crescent of blinding white beach. Visit Stingray Cove to feed and learn more about the gentle creatures. Ride your horse to a deserted beach and into the surf. Or, take your kids to Half Moon Lagoon, island's aqua park and children's playground. Part of the Bahamas, Half Moon Cay lies about 100 miles southeast of Nassau and is visited on nearly every Caribbean itinerary.
Horseback Riding by Land & Sea: Head to the high point of the cay on horseback before a brisk ride in the surf.
Aqua Trax Adventure: Get on a personal watercraft for a tour of the island, then test your skills on an obstacle course.
Deep-Sea Fishing: The waters around the cay teem with wahoo, snapper, grouper and other fish. Catch (and release) them.


In June this year we put together a list of more than 60 companies doing travel technology in Ireland, a mix of homegrown startups and foreign direct investment. The list was published in Dublin Globe, the newsletter of the Dublin commissioner for startups.
NB: This is a viewpoint from Dublin Travel Massive chapter leaders, Kevin O'Shaughnessy founder of Cityhook, and Mark Lenahan, independent advisor to airlines, travel tech companies, and loyalty programs.
This Tnooz article provides a platform for a somewhat deeper discussion of why travel is such an important sector for Irish technology companies, and gives us a chance to provide some views on the history and current state of travel technology here in Ireland.
Travel technology in Ireland stretches back many decades. To this day, Aer Lingus is one of the few carriers still operating its own reservation system, "Astral", started on an IPARS System/360 mainframe first installed by IBM in the late '60s.
"Aer Lingus, although a small airline, was particularly strong at developing and selling its ASTRAL Res/DCS to many hosted airlines, ground handlers and res/distribution agencies from the 1970's through to circa 2002", Kevin Pryor, Joint MD of Liberator.aero recalls. "Airlines that used it include Kuwait, Air Malta, Cyprus Airways, Air Zimbabwe, Egyptair, Hamburg Airways, Icelandair, and Bangkok Airways".
In 1971, Aer Lingus spun out Cara Computing to provide airline technology services. At that stage, Ireland was already exporting travel technology and services to the wider airline industry.
While this was happening the airline industry used either proprietary networks or the SITA network to communicate between airlines, airports, agencies, and global distribution systems (GDSs).
In Ireland, Wescan Europe Limited (a division of Westinghouse Canada), was set up in 1980 to make airline network and terminal equipment. Datalex was founded five years later by Neil Wilson and Steve Metzler, focusing initially on airline computer network devices and software.
In the early years they attracted a number of key people from Wescan including their current CEO Aidan Brogan, and also John McQuillan and John Lambe, who along with Sean Mac Roibeard went on to found OpenJaw Technologies in 2002. Former Datalex employees Dave O'Flanagan, Alan Giles, and Dermot O'Connor went on to found Boxever in 2011.
SITA - having grown beyond networks into airport and airline PSS systems - made a major investment in Ireland in 2003 with the acquisition of Eland Technologies.
The next year SITA founded Aviareto - who manage the international airline registry - in partnership with the Irish government. SITA still have a major development centre in Letterkenny.
Another key part of the airline eco-system in Ireland is the aircraft leasing industry, sparked by Guinness Peat Aviation (GPA) in the 1970's, described below. The founder of GPA, Tony Ryan, would eventually go on to co-found Ryanair and establish a startup hub at the Ryan Academy.
Later, his son Declan founded Irelandia Aviation, itself responsible for establishing and developing low-cost carriers all over the world, including Allegiant Air, Tiger Airways, VivaAerobus, and Viva Columbia.
Declan contributes back to the wider entrepreneurial environment in Dublin with funding to Frontline Ventures and some personal investing, such as Coindrum.
Back on the ground, accommodation technology is also a thriving industry in Ireland. The star of Irish startups is probably Hostelworld, founded by Ray Nolan and Tom Kennedy in 1999 and set for a major IPO 9 years later.
Ray subsequently acted as Chairman in Skyscanner and Tom went on to found Homestay, bringing several Hostelworld people with him. Tom also invested in MeetingsBooker. Another Hostelworld (and Ryanair) alumni, Santina Doherty, is co-founder of Unravel Analytics.
Today, aviation leasing in Ireland accounts for one in five passenger planes globally, or approximately half of the world's leased aircraft. Of the 15 biggest aircraft lessors in the world, 14 have operations in Ireland.
According to Boeing, the number of aircraft flying which are leased has grown from 2% (1980) to 40% (2014). Leasing aircraft allows airlines to manage the capital risk from operations from seasonal or macroeconomic factors — whether a small, growing airline or a flag-carrier getting ready for a busy summer season.
Following the 1970's oil price shock, an Aer Lingus manager, Tony Ryan, began leasing aircraft and in 1974, with funds from Aer Lingus and the Guinness Peat investment bank, set up Guinness Peat Aviation (GPA). GPA went on to become the largest aircraft leasing company in the world at one point, and its valuation reached $4Bn at peak.
A decision to float shortly after the Gulf War in the early 1990's proved fatal. To save the company, they sold assets to GE Capital Aviation Services, including aircraft, transfer of staff and options on shares.
The team and skills built in GPA are now part of the management teams of other leasing companies [GECAS, CIT, AerCap (ILFC, Genesis Lease, GPA), Pembroke Capital, International Aircraft Management Group, Babcock & Brown and Aircastle].
This talent pool, along with tax incentives, is what is attractive to this sector, with over $120Bn of funds under management in Ireland.
A number of NGOs, semi-state bodies and government departments exist to support technology and investment in Ireland, the two largest being IDA Ireland, promoting foreign direct investment, and Enterprise Ireland, which supports development and growth of Irish businesses in global markets.
The IDA attracts companies such as Airbnb to Ireland while Enterprise Ireland provides funding and a network of market advisors in overseas offices to assist export-led companies (whether startup or established businesses).
A committed EU member, with a largely English speaking and university educated population, Ireland has attracted more than 1,200 foreign companies. These include Accenture, Adara, Adobe, AirBnB, Allianz, Apple, CA, Dell, Dropbox, Ericsson, Facebook, Fujitsu, GM, Google, Hertz, HP, IBM, Intel, Logitech, Oracle, PayPal, Philips, Radisson, Sage, SAP, Siemens, SITA, Starwood, Sun, Symantec, and Xerox.
Ten accelerators and 30 university-based collaboration labs provide the assistance necessary for some startups.
While preparing an exhaustive list of travel-related technology based in Ireland, we found a number of different categories emerging.
In airline IT and distribution technologies, Ireland is home to Datalex, which lists clients like Delta, Virgin Atlantic, JetBlue and Aer Lingus. OpenJaw Technologies was originally founded in Dublin, with British Airways, S7 Airlines, Cathay Pacific among its clients. Datalex is publicly-traded; OpenJaw was recently acquired by TravelSky.
Software companies with a presence in Ireland that help lessen the load for airline/airport operations include Planitas, Liberator and security software company Daon.
In mobile software development, Pulsate and FeedHenry (Redhat Mobile) have an interesting client list in travel. Dublin was also the starting point for Mobile Travel Technologies (MTT, now part of Travelport), which works with Odigeo, BCD and Easyjet.
Big data and analytics companies founded in Ireland include Boxever and Phocuswright award winner Unravel. Adara also has an office based in Dublin.
Ireland is also a hub for inflight content and technology. Retail inMotion was founded here, which transformed inflight sales (now part of LSG Sky Chefs).
Many of the inflight movies we watch on more than 50 airlines around the world are supplied and licensed by Inflight Dublin, and Arconics provide a range of inflight software used by crew and passengers alike on planes globally.
The Irish Financial Services Centre, situated on the opposite side of the river from the "Silicon Docks", attracts financial services companies like credit card payment service providers (PSPs), including First Data (now owned by Mastercard).
Dublin was where Realex Payments started, with airlines like Aer Lingus and Virgin Atlantic among its ecommerce clients.
In County Kerry, on the opposite side of the country, are three of the industry's biggest dynamic currency conversion (DCC) providers: Continuum Commerce, Fexco and Monex Financial Services. DCC, by all accounts an Irish invention, allows airlines, retailers and travel companies to offer payment in the card holder's currency rather than the local currency or the pricing currency.
Essentially the airline and DCC partner compete with the card issuer for currency conversion and a share of the commission.
Mobacar, the car rental and local transport aggregator, was Phocuswright European Travel Innovator of the Year 2014. Another Phocuswright award winning startup is transport technology company Indigo.gt.
Accomodation technology companies Netaffinity and Avvio are based here. Destination content companies TripAdvisor and Lonely Planet also have offices here. Recently, Acteavo joined forces with Treksoft to open their first office outside Austria.
Starting a business is a challenge -- in the travel industry, doubly so. That said, Ray Nolan (Hostelworld founder), speaking at Dublin TravelMassive, said that there's still a lot of opportunity in travel software.
While hard to quantify, Dublin has access to networks of travel entrepreneurs at every level, all eager to help build the next big thing.
Ireland is similar to the UK in that it is quite simple to form and operate a company, relative to requirements facing budding entrepreneurs in continental Europe. "Red tape" and corruption here is low by most indices.
Travel and transport-related companies such as Indigo.gt, Boxever, Dropcar and iCabbi have all been through the NDRC acceleration programme. Venture capital is close by, where individual investors take the lead in supporting travel technology companies.
However, the London and European investment markets are only an hour away for Dublin-based companies. Funds from further afield, such as Polaris in Boston, have helped entrepreneurs to scale.
The state agency, Enterprise Ireland, provides a number of different supports both for startups and scaling established business with a goal of growing Ireland's export-based economy.
Networking is vibrant, meetups can easily fill every evening with interesting opportunities to meet potential collaborators and partners.
We run the TravelMassive group in Dublin, which has a strong slant towards travel technology. Tnooz ran a hackathon in the city in 2015, for instance.
We see companies starting, as well as companies scaling to trade sale — such as CarTrawler — or floatation — such as Datalex. There's no shortage of inspiration or ambition.
Given our island geography and long history of emigration, it probably isn't surprising that Ireland has such a strong focus on travel and transport. Ryanair, Europe's largest airline and 6th in the world by passengers, started here and is headquartered in Dublin.
In the first six months of this year Dublin airport handled 13 million passengers, even though Ireland only has a population of 4.5 million. As a nation, we love to fly.
NB: This is a viewpoint from Dublin Travel Massive chapter leaders, Kevin O'Shaughnessy, founder of Cityhook, and Mark Lenahan, independent advisor to airlines, travel tech companies, and loyalty programs.


text:
Q: How to stop IDM from grabbing video/audio Every time a video/audio streaming starts the Internet Download Manager (IDM) feels that there is a multimedia content on the page and allows you to download that multimedia content.
I don't think it's possible to prevent IDM from grabbing video/audio but is there a way to fool IDM to get a wrong video instead or make it very hard for IDM to guess which is the real video/audio playing?
EDIT:
Actually My Question was from the server side point of view not the client running an IDM. So i guess the misunderstanding here is my fault. Many good answers here but not the one i was looking for

A: You can prevent IDM from starting the download using two ways,

*

*The first way is by specifying file types that IDM should automatically grip, so you can exclude the certain file type, for instance "MP3" or "MP4".
To do that configuration, you have to click on "Downloads" menu in the IDM's main GUI, and then select "Options", a new small window will appear, choose "File types" tab from it. Now in the first text input box you can add or remove the file types you want

*The second way is by specifying certain sites that IDM shouldn't automatically download from them. You can find an input text box below the text box in the previous way which you can use for that purpose.
for example you can add something like this:
dropbox.com
to prevent any automatic download from Dropbox site
Note:

*

*In the first way, you can enforce IDM to download from a specific link when its targets file type is not listed on the list of automatic grabbing types. to do that you should first click on "Keys..." button which is located in the "General" tab in the "Option" window, and from the window that will appear, make a tick in the second choice which will allow you specify a certain key that could be held while clicking on the desired link in order to enforce the IDM to start the Download

A: You need to open Options->General IDM dialog and press Edit near Customize IDM download panels in browsers.
Then enable Don't start downloading from web-players automatically option (arrow 1 on the image) and press OK.

A: You can stop automatic capturing from browser by going to Options > General and uncheck the browser you are currently using this will prevent any download from starting automatically

A: If you want to temporary disable IDM for single download you may hold Alt  button while clicking on the download link to prevent IDM from taking the download.

A: You need to open "Options->General" IDM dialog and press "Edit" near "Customize IDM download panels in browsers".

Then enable "Don't start downloading from web-players automatically" option (arrow 1 on the image) and press "OK" (arrow 2 on the image).

source: http://www.internetdownloadmanager.com/register/new_faq/video14.html

A: You can press Alt key while downloading file.

redpajama_set_name: RedPajamaStackExchange


text:
Home news Cegedim PMR users to get faster acceess to SCR
Cegedim PMR users to get faster acceess to SCR
By Keerthi Mohan -
(Photo: iStock)
Users of Cegedim Pharmacy Manager PMR system can now quickly access additional patient information, the company has said.
Pharmacy teams will obtain the access following successful integration of the software with the NHS Summary Care Record (SCR) service.
"Pharmacy professionals logged in with their Smartcard can click straight through to a selected patient's SCR without having to log into the NHS portal separately and completing a manual search," the company said.
Quicker access to SCR – which provides a full picture of a patient's health and medication history – allows pharmacies to provide improved patient care and view critical information, such as the Covid-19 shielded flag, it said.
Commenting on the development, Steve Bradley, group managing director, Cegedim UK, said: "Integration with the SCR positively contributes to patient safety, efficiency and effectiveness, which are three tenets of service delivery that we feel very strongly about.
"By having a patient's record easily accessible from the PMR, not only can pharmacists mitigate the risk of prescribing errors and patient misidentification, but they can also save a significant amount of time, which opens up opportunities for value-added services."
Pharmacist Tom Bisset from Ward Green Pharmacy in Barnsley added: "Having speedy access to the SCR is helping the service we can provide to patients and reducing the need to log into a separate portal to access the SCR or the need to telephone the GP practice."
Previous articleExclusive: 'I've always dreamt of having queues outside my pharmacy and for once in my life, I have them and still do'
Next articleUK extends coronavirus self-isolation to 10 days from seven; Hancock worried about a second wave
Keerthi Mohan

redpajama_set_name: RedPajamaCommonCrawl


According to a German legend the snow was the only thing left after all things in the world already got their color. The snow then asked around if anything would be willing to share its color. The earth did not answer at all, the grass pretended not to hear the snow and the rose was too haughty to share its color. Heavy-hearted the snow continued its journey. At the edge of a forest it met a tiny white flower and asked if it would be willing to share its beautiful color. 'Why not, take as much as you need' answered the flower and thus the snow got its color and the tiny flower the name snowdrop as well as the privilege to bloom first without being hurt by the snow.
Tiny yellow stars, or the center of Zinnia elegans aka Z. violacea.
A 'Gold' hybrid of Lantana montevidensis and a visitor.


All licences issued in the European Union are accepted.
Driver's licenses from non-EU countries (except Switzerland) are accepted if you have a visa in your passport and at the time of rental have not been in Europe for longer than 6 months. Longer than that, you need to get a driving licence from an EU country.
If your domestic driver's license is printed with non-Roman Alphabet (Arabic, Japanese, Cyrillic etc), an International Driving Permit (IDP/IDL) or an official translation in English is required when you drive in France. Please note that an International Driving Permit (often referred to as an International Driving Licence) does not replace the requirement for a regular driver's license. And you must carry your current overseas driver's license, IDP or translation with you all the time when driving in France.
To drive in France, the driver must present a valid national driver's license that has been held for at least 1 or 2 years (according to different car rental company).
Some French car rental companies require you to have a photo ID license. If your foreign license does not have a photo ID, you should get an IDP before travelling to France if you intend to rent a car. UK drivers with the new-style photo card license will need both the paper counterpart and photo card. UK license holders who have a paper license only will also need an official photo for identification when driving in France.
To rent a car in France you must be at least 18 years old (age may vary by car category). Each car rental company has its own age requirements and a deviation from the minimum age is possible depending on the vehicle. If you're 18-25, you are likely to have to pay a young driver fee.
Driver's licenses from non-EU countries (except Switzerland) are accepted if you have a visa in your passport and at the time of hire have not been in Europe for longer than 6 months. If your domestic driver's license is printed with non Roman Alphabet (Arabic, Japanese, Cyrillic etc), an International Driving Permit (IDP/IDL) or an official translation in English is required together with your driver's license when you drive in France.
To drive in France, the driver must present a valid national driver's license that has been held for at least 1 or 2 years(according to different car rental company).
Service code: 3743418113 | © 2019 Easy Tour International Ltd. All rights reserved.


1) Absolutely no servo signal resolution reduction. Even those comercial ones claiming for more than 200 steeps resolution are a POS in softness and proportionality.
2) 1:1 mix but: A) each channel must individually be able to reach the 100% servo travel. B ) When mixed the sum of both signal will never go beyond the 100% servo travel range.
Have no possibility of doing it from the RC-TX as the mixed signal must come from an on board Gyro.
I found this unit http://www.gadgetparadise.com/121901/ They shows free info. The only problem is to know if there is any microchip equivalent to the ATtiny13 used on it. Have no idea but seems to me this chips use different programmer boards than the PICs.
As a PIC I'd use my usual 12F675, providing the inputs aren't simultaneous (Futaba PCM). Fine with 1us resolution (1000 steps on standard throws).
Any luck with the hi res mixer search ?
I need a couple too.
No, I have had no time to go ahead with that but hope to start with it at the end of the next week. It´s the only option I have for now to finish my own UFO proyect so I must do it ASAP.
Thats why Im looking for a couple, Im building a quad.
What mix scheme are your trying to use that needs only two mixers?
Mine is based on a 4 servo ccpm mix from a AP2000i electronic mixer running the roll and tilt gyros plus the pitch channel to each ESCs. Then for yaw I´m planning to add a third gyro to the rudder receiver output plus a servo signal buffer to support four outputs, to four servo mixers. Each mixer will manage the signals from the AP2000i and the ones from the rudder to put them out to the ESCs.
Mine is based on a Helicommand. I plan to run the yaw gyro output into the 2 mixers to mix the yaw with the pitch and roll inputs to the Helicommand.
Seems like we are on similar paths.
Being the airscrews turning two by two in different directions (fore/aft and left/right) and needing to vary the tork relation between both pairs/axis to get the yaw control, how does any change before the helicomand imputs provide the required rpm increase in both engines fom the same aixs while reducing the two of the other one in the same ammount.
Both my roll props are RH and both my pitch props are LH so if I mix the yaw so that as the yaw signal increases it slows the RH props and speeds up the LH props it will turn and have no effect on pitch roll or alt.
By the way which speed controllers are you going to use ?
After thinking about it I see you are right, it will take 4 mixers.
Think on this single channel. your externaly mixing rudder and ail to get a single output signal going into the HC for mixing. At the Helicomand input you will in anyway have a signal that once procesed will result in an aileron axis position where one engine will increase the rpm while the other is reduced but never both increasing or reducing at a time.
That´s why I found as the only way to do it, make the yaw mix just between the Ap2000i (HC) and the ESCs.
They are the cheapest ones I found and far away from quality winners but many guys have succesfully used them for the same project kind of machines.
I ordered at the same time a couple of mixers http://www.hobbycity.com/hobbycity/store/u...?idProduct=6321 but they are a POS and only the Futaba stile conectors will be saved from trash.
Wow those prices are amazing, it will cost me much more in the UK.
Are you sure the 10A controllers will be ok ? I was thinking a bit bigger.
I´ve not test them right now but as I said this is what many others are using without problems even loading the machines with photo cameras.
Just me being over carefull I guess.
When do you hope to have it flying ?
The airframe is ready with the engines fitted, the ESCs soldered and all the wirings ready. The Ap2000i is programed and the three gyros wayting to be placed. So only the f.....g Mixer chips are left. Once I get the four chips it requires no more than a couple of hours to make the little mix boards and solders to be ready for the maiden flight. So as soon as I find who can make it for me it will be ready.
Have you started your frame?
No I have been working on another project for the last couple of weeks so nothing built for the quad yet. With luck I can get started soon, I will have all the parts by next week.
I will be very interested to hear how yours flys as its so close to what I am making. I was starting to think everyone else was using purpose built quad boards.
I was starting to think everyone else was using purpose built quad boards.
Your not far away from true. I have heard only from a couple of guys that buildt them the way we want to do instead of going ahead with purpose boards, but those guys did it long time ago with old technic equipment and materials. Having at home the most expensive parts for the projec I think it´s worth to try it by mi own spending some Eur in those little engines and ESCs.
What we want to do using what we have is very close to what you can see in this forum http://www.rcgroups.com/forums/showthread.php?t=768115 They use a draganflyer board which has three gyros plus a IR sensor for outdoor stabilization. I can fit the IR sensor on my AP2000i as well, and so can yo do using your optic sensor and superior inertial configuration. So why can it not be succesfully done? even if it finally can´t, then I will start building a four engine depron airplane with the parts.
I was just looking at those mixers you linked to, do you think 1:1 mixing is going to be ok ?
I was thinking of a much lower value for the yaw.
Sorry Terry, I didn´t realize you have a pending question here.
I would start using 1:1 mixing and reduce the rudder ATV value if needed.
It requires to change the supplied receiver (walkera PCM, or use an original Walkera TX if you can get one) to your one and to add some opto isolators to make it compatible with brushless engines. Other than that it comes with three gyros plus accelerometers, mixing board, two led outputs, two aux channels for camera operation (shutter and tilt) and a pot to set the right stabilization gain. sure it´s not a Mikrokopter PCB but for the price I decided to try it.
I also got a new battery pack for my MaxiJoker2 and I need the AP2000i to be onboard asap so the UFO china board is the only option I´ve to play an UFO without spending too much money.
Dose that mean your AP2000i quad project is dead ?
Unless I´m unable to make the little walkera-UFO board work right I will no longer go with the AP2000i based one. Sorry but I can´t fight in all fronts at the same time and need the AP2000i working in my heli again.
May be it´s better this way so we both can afford the same goal of having our own UFO starting from two different points. The cost of the four mixers required is equal to the china board wich requires at the same time a PWM-PPM converter and a RC-RX adaptation to substitute the original Walkera. I will lose the IR stabilization capability but hope to be able to live with that if the gyro-accelerometer combo included in the PCB works as expected.
Later this evening I will post here the last v-mixer scheme I found that was the one I would use as it´s basec on a PIC and not on a Attiny, hope it helps you.
Later will try to find the other one with the hex code.
I have got some of those cheap mixers now, I will give them a go first but If they fail I have also programed my own 12F675 to give what ever mix I need by altering the value in the code before programing.


A new species of Euptychiina, Erichthodes eremita Lamas, Willmott & Radford, n. sp., is described and illustrated. DNA sequence data suggest that the new species is sister to a species currently placed in Erichthodes Forster, 1964, although ongoing revision of the generic taxonomy of the subtribe might result in the reclassification of both of these species in future. The new species is known from the eastern Andes of southern Ecuador and adjacent northern Peru, where it is a rare inhabitant of stunted, 'elfin' cloudforest confined to ridge and mountain tops.


text:
La plerocercoide es el último estadio larvario de diversos cestodos con ciclos de vida acuáticos, como es el caso de Diphyllobothrium latum. En Diphyllobothrium, el procercoide, estadio larvario previo, es ingerido por peces como el lucio o el salmón, y en su interior pasa a la fase de plerocercoide, que continuará su ciclo de transformación en un mamífero ictiófago al ser ingerido por éste.

Cestoda
Larvas

redpajama_set_name: RedPajamaWikipedia


Minisart SRP syringe filters with a clean and chemically inert PTFE membrane. The units are ready-to-use and allow for simple, rapid and reliable ultracleaning of small volume samples for HPLC or GC analysis, which require an even more chemical resistant unit than Minisart RC, e.g. for solvents such as acetone, dimethylformamide and DMSO, or for aggressive aqueous liquids. Minisart SRP syringe filters ensure rapid small volume sterilisation with maximum user convinience. They offer high flow rates at low inlet pressures. Minisart SRP15 with small spike outlet is recommended for filtration of narrow-necked vials.


The tarpon is one of the deadliest sea predators in the Atlantic ocean. Watch this monster and it's hunting technique as it's main strength is it's enormous strength and explosive acceleration.
How Did Fish Survive This Catastrophe?


text:
Home › Economy & Finance › Coronavirus Pandemic Crisis Forces Airbus To Scuttle Plans For New A321 Plant
Coronavirus Pandemic Crisis Forces Airbus To Scuttle Plans For New A321 Plant
By admin2 on April 10, 2020 • ( 0 )
In what was the latest exemplification of the impact of the coronavirus pandemic ripping through the global airline industry, the plans of aircraft making giant Airbus to create a new assembly line for its A321 airliner has have been cancelled by the company.
The plans for the creation of the line at its Toulouse base in south-west France was announced by the company back in January this year. At that point in time, the primary concern for the company was to enhance capacity to meet the record demand for the jet which has the capacity of flying more than 200 passengers and is suitable for short- and medium-haul routes.
Just a day before the Airbus announcement, the decision to defer the delivery of 24 Airbus planes was announced by the budget airline easyJet. This measure was taken by the airline to meet the demands made by the airline's founder and largest shareholder, Stelios Haji-Ioannou, who had been demanding that the airline cancel the order altogether.
On Wednesday, Airbus gad said that it would be cutting down the number of aircraft that it would build by at least one third in response to the anticipation that the coronavirus pandemic will continue to be adversely impacting the global aviation industry for a longer time even after the easing of travel restrictions.
There can be a 44 per cent drop in industry passenger revenues compared to the numbers of 2019 at $252bn, according to an estimate published by the International Air Transport Association (IATA) last month.
"Our plans for an A321 line in Toulouse are paused, on hold," said an Airbus spokesman. "When we see rates going up again, we will reconnect to the plans."
Airbus would "hibernate" new investments to save cash, said Guillaume Faury, the chief executive of the aircraft maker.
French unions said they would fight for the A321 plant.
"Unlike Guillaume Faury who wants to halt non-essential investment, we think the arrival of a new A321 line … factory must be maintained," said the CGT union official Xavier Petrachi.
It was just about a fortnight ago that the IATA had published the latest estimates about the impact on the industry of the coronavirus pandemic.
"The airline industry faces its gravest crisis. Within a matter of a few weeks, our previous worst-case scenario is looking better than our latest estimates. But without immediate government relief measures, there will not be an industry left standing. Airlines need $200bn in liquidity support simply to make it through. Some governments have already stepped forward, but many more need to follow suit," said the trade body's chief executive, Alexandre de Juniac.
(Adapted from TheGuardian.com)
‹ Major Oil Producers Agree On A Possible Production Cut To Stabilize Price
3M files lawsuit against Performance Supply LLC for alleged price gouging by as much as 600% ›
Categories: Economy & Finance, Regulations & Legal, Strategy, Sustainability, Uncategorized


This Achievements guide will show you how to get the Achievements "Aquire Hardware." The description explains to you that you must smelt an Iron Ingot, or Iron Bar.
1. First, you have to get the Iron. Go inside a cave and look for a block that has small chunks of peachy-colored pieces on it. When you mine and collect this block with your Pickaxe, the block will be called Iron Ore in your inventory.
2. Once you have the iron ore you need, you need to make a Furnace to actually smelt it into an Iron bar. A Furnace is made by putting Cobblestone all around the crafting space in a Crafting table. This should be a total of 8 pieces of Cobblestone.
3. Once you have the Furnace, you just put the Iron ore into the ingredients slot and for the fuel slot, you can just put Coal or Charcoal into it.
In a little while you'll have an Iron ingot plus another Achievement unlocked!


Kelly KM. Biological basis of cleft palate and palatal surgery. In: FJM Verstraete, MJ Lommer, B Arzi (eds), Oral and Maxillofacial Surgery in Dogs and Cats (2nd ed). Saunders: Philadelphia.
Campo S, Kelly KM Rohlman DS. Occupational safety, health, and well-being programs in small Midwest enterprises. In: HL Hudson, JA Nigam, SL Sauter, LC Chosewood, AL Schill, J Howard (eds), Total Worker Health: Integrative Approaches to Safety, Health, and Well-being.
Fix J, Annesi-Maesano I, Boulanger M, Cheng S , Cortes S, Dalphin J-C, Dalvie A, Degano B, Douwes J, Eduard W, Elholm G, Ferreccio C, Frost G, Harding A-H, Jeebhay M, Kelly KM, Kromhout H, Lebailly P, MacFarlane E, Maesano CN, Mitchell D, Naidoo S, Negatu B, Ngajilo D, Nordby K-C, Parks C, Sandler DP, Schenker M, Shin A, Sisgaard T, Sim M, Soumange T, Taylor M, Thorne PS, Yoo K-Y, Hoppin JA. Gender differences in respiratory health outcomes among farming cohorts around the globe: findings from the AGRICOH cohort consortium.
Henneberger PK, Humann MJ, Liang X, Doney BC, Kelly KM, Cox-Ganser JM. The association of airflow limitation with occupational exposures in a sample of rural adults in Iowa.
Plombon SB, Humann MJ, Liang X, Kelly KM, Henneberger PK. Association of chronic bronchitis and airflow limitation with lifetime and current agricultural activities.


text:
The Changing Face of Alzheimer's Disease: Current Knowledge, Areas of Research Interests, Drug Development
Alzheimer's disease (AD) was first described over a century ago and since then, the major histologic features of the disease have been extensively studied.
Amyloid plaques and phosphorylated tau protein tangles do not reveal the entire story for development of Alzheimer's dementia. Many efforts related to therapeutic and pharmacologic interventions have fallen short. It is time to re-evaluate this devastating disease, look at possible etiologies and focus research in different areas of understanding in this complex disease.
As the world's population ages and demand for health care resources increase, society will have to accommodate the increasing burden of chronic diseases characteristic of the aging population. Prevention and treatment of AD becomes imperative. Research must look into different avenues of disease development. Currently, the only consistent research finding that is effective in prevention of disease is lifestyle modification: healthy diet, regular exercise, smoking cessation and moderate alcohol intake. Lifestyle modification has influence on the development of disease and may be the best way to avoid it altogether since therapeutic alternatives are not effective.
Current Understanding of Alzheimer's
Alzheimer's disease (AD), currently the most common form of dementia in the U.S., is reaching epidemic proportions. Recent data estimates 5.7 million Americans are living with AD, and an additional 11.6 million have mild cognitive impairment.1 The rapidly aging U.S. population means the number of AD cases will most likely triple in the next 30 years.2
Not only is the U.S. impacted by an aging population, worldwide the number of people living with dementia in 2017 was estimated to be close to 50 million. The number of dementia cases globally will nearly double every 20 years, to 75 million in 2030 and to 131.5 million in 2050. China, India, and other developing nations have the fastest-growing elderly populations due to improved health care, which has extended life expectancies.3
Women make up the majority of individuals living with AD, attributable to greater longevity and biological factors.4 Lifetime risk of AD for women at age 65 is 21.1% and for men is 11.6%.1, 5 Survival after diagnosis is influenced by multiple factors, including age at diagnosis, gender, presence of psychotic features, motor system involvement, and medical comorbidities.6 On average, survival after diagnosis ranges from four to eight years if comorbid conditions are present, and best-case scenarios for survival may be up to 15 to 20 years.6, 7
Unfortunately, neither a cause nor a cure for this devastating disease has yet been found. Most recent research efforts have focused on the role of amyloid plaques and neurofibrillary tangles (NFTs). These abnormal proteins are found in the brains of individuals with AD and are composed primarily of phosphorylated tau protein. It has become clear, however, that abnormal proteins by themselves do not explain the disease's etiology. Further research into the systems that support protein homeostasis in the brain and regulate inflammation and protein removal is underway, and may be what is needed to develop a more complete understanding of the pathology of AD.
Amyloid Plaques and Neurofibrillary Tangles
The characteristics of amyloid and tau proteins in brains of individuals with AD were elucidated in the 1980s. Both proteins are generated in the normal course of brain function, but can become toxic if they aggregate abnormally in the brain.
The amyloid beta (Aß) protein is a peptide formed by neurons in the cortex of the brain – particularly in the hippocampal area, which is where memory function is housed. However, as Aß is released into the brain's extracellular spaces, it can become distorted, forming chains of Aß oligomers that conglomerate to form insoluble amyloid plaques. These plaques grow in size and interfere with neuronal function by destroying dendritic connections between cells.
Amyloid plaques accumulate in the brain in a predictable manner,8 and their presence can be detected in the brain by testing for it in cerebrospinal fluid (CSF) and by PET (positron emission tomography) scans using radiotracers that bind selectively to Aß protein. PET scans are reliable predictors of brain amyloid plaque burden. These imaging findings, however, are not specific to the brains of individuals with AD. Plaques are also found in brains of individuals with other neurodegenerative disorders, such as Lewy body dementia and cerebral amyloid angiopathy, and in those of cognitively healthy older individuals as well.9
NFTs are composed of hyperphosphorylated tau protein. When normal, this protein is part of the structural support system of neurons that maintain integrity of the neuronal axon. However, when tau protein accumulates, it leads to interruption of normal neuronal function and ultimately to death of neurons. Today, deterioration of cognition is seen as correlating more strongly with tau protein burden and distribution than with that of amyloid plaques.10
Autopsy findings of people with late-onset dementia, particularly the oldest old (now frequently defined as age 90 and older) and even individuals with mild cognitive impairment (MCI), will exhibit multiple pathologies at autopsy, including vascular brain injury, Lewy body dementia, and hippocampal sclerosis.11, 12
AD: A Vascular Disease?
Large epidemiologic studies and an accumulation of scientific data associate vascular risk factors and vascular markers with subsequent development of dementia. The large database of 7,000 subjects of the Rotterdam Study has followed elderly individuals since 1990. This study group was compared to an age-matched control group. A series of reports comparing those who develop dementia and the nondementia group identified an association between the presence of vascular risk factors and the development of
AD in older individuals.13,14 Risk factors confirmed by the Rotterdam Study as well as other independent studies include diabetes mellitus,15 atrial fibrillation,16 smoking,17, 18 and atherosclerosis.19 Each of these risk factors directly influences perfusion to the brain in a negative manner.
Hypertension has been demonstrated in many studies to be a contributing factor to AD. Indeed, long-term follow-up of middle-aged men with hypertension in the Honolulu-Asia Aging Study noted a higher burden of NFTs and brain atrophy post-mortem compared to normotensive individuals with AD.20 Additional studies have substantiated the ill effects of long-term hypertension after following a large group of individuals with stroke history. In the 1990s, the FINMONICA Stroke Register in Finland, for one, began to track trends and determinants of vascular disease among participants. Early studies noted a relationship between middle-aged individuals with hypertension and hyperlipidemia and subsequent development of MCI and AD: the higher the blood pressure and lipid abnormalities, the higher the risk of developing cognitive impairment later in life. When both blood pressure and cholesterol are abnormal, the risk for both MCI and AD increases in a synergistic manner.21
Knowing that vascular risk factors can be modified, a group of researchers recently published their findings on the risk of developing dementia when healthy lifestyle habits are followed in individuals with varying degrees of genetic propensity for dementia. Results of the study demonstrate that unhealthy lifestyles with any degree of genetic predisposition will increase risk for dementia development. Hazard ratios, in this study, increased with dose-dependent exposure to unhealthy life styles combined with high polygenic risk scores. (Unhealthy lifestyles are defined in this study as: smoking, poor diet, no regular exercise, and high alcohol intake.) Controlling risk factors for vascular health is important and consistently demonstrates protective value in preventing dementia.22
AD: An Inflammatory Disease?
Another area of research which has grown in importance is the role of neuroinflammation and its contribution to the development of AD. Post-mortem brain tissue indicates there is a prominent inflammatory response to the deposition of abnormal proteins in the brain. Aß peptides have been shown to be cytotoxic in laboratory analysis, stimulating synaptic loss, mitochondrial dysfunction, and eventually neuronal death.23
Accumulation of cytotoxic misfolded amyloid protein in the brain is an example of a proteopathy, a condition in which the integrity of protein is controlled through phagocytosis and degradation of abnormal proteins in a healthy brain. However, AD creates an unhealthy environment where microglia cells have a central role in clearance of toxic proteins. With aging, disease, or genetic mutations, microglia cells become dysfunctional. Similar to other situations in which inflammation is nonproductive, microglia activity causes harm through propagation of inflammation by antigen-specific and nonspecific mechanisms. One novel therapeutic approach is to control brain inflammation through the inhibition of microglia activity.24
AD: An Infectious Disease?
Many aspects of AD may be similar to known physiological responses to infection. One researcher has even posited a possible AD germ.25 Clues that an infectious etiology could be the root cause for AD include observation that various antibiotics have been reported to have beneficial effects on patients with AD.26
University of California San Francisco (UCSF) scientists have indicated that AD could be the result of tau and amyloid proteins behaving more like prions (i.e., infectious protein particles). Prions are proteins lacking nucleic acids that have the genetic capability to self- propagate. Two examples of cognitive-related prion diseases are Creutzfeldt-Jakob disease and mad cow disease.25 UCSF researchers have developed analytic tools to identify and quantify prion levels. Tau prion levels appear to correlate most closely with disease activity in middle-aged onset AD. The higher the levels, the higher the disease activity and risk for death. In older individuals with AD (late-onset), tau prion levels are much lower, suggesting slower propagation time and a less aggressive form of the disease.27, 28
Another pathogen of interest is the herpes simplex virus (HSV). Researchers have demonstrated that Aß and fibril development pathways mediate antimicrobial activities in the brain. Amyloid oligomers bind the glycoprotein molecules on the surface of herpes virus to engulf the virus and render it inactive. Herpes virus subtypes 6A and 7 have been identified in significant amounts in the brains of individuals with AD. In addition, there is a link between viral activity in the brain and pathologic changes of the brain in those with late-onset AD.29
Therapeutic Developments
Drug development for the treatment of AD has been very slow and disappointing. Initially, acetylcholinesterase inhibitors (AChEls) were approved in 1993 by the U.S. Food and Drug Administration (FDA), based on the understanding that an acetylcholine deficit develops in the brain as a result of neuronal loss. AChEIs are considered symptomatic therapies, as they do not alter the progression of the disease, they do not have neuroprotective qualities,7 and no proven benefit has been demonstrated in MCI.2 Namenda (memantine), the only FDA-approved AChEI for moderate dementia, has been used successfully in treating behavioral disturbances in the advancing stages of the disease, but it has not been shown to be effective for arresting disease progression.30
Presently, approximately 200 compounds are being researched and developed for AD treatment or prevention. Challenges exist with the research and development of AD-specific pharmacologic agents, particularly since the disease moves very slowly and there is a very long preclinical interval before symptoms develop. Clinical trials need to extend over years and even decades, making trials expensive and lengthy.31
Biomarkers used to identify abnormalities in CSF and brain imaging are being used more frequently to identify patients for drug studies, especially those with preclinical and early symptomatic disease. Going forward, biomarkers will likely become the tool of choice to provide an objective measurement of response to potential therapeutic modalities, which should shorten time for clinical trials.32
Tomorrow's drug therapies will likely continue to unravel the mystery behind amyloid diseases, targeting abnormal production and aggregation as well as clearance of amyloid protein. Several immunotherapies are under investigation to promote clearance of Aß, including passive immunization with monoclonal antibodies, either directly or through the activity of microglial cells or complement activation.33
Another area of research focus is chaperone molecules. These molecules are proteins that appear to inhibit the propagation of deformed amyloid fibrils and, in turn, reduce the toxicity of the abnormally folded amyloid protein. Harnessing the function of chaperone molecules could have therapeutic potential as a way to reduce the production of amyloid deposits in the brain.34 It is interesting to note that pathologic amyloid fibrils are associated with about 40 different diseases in addition to AD, including type 2 diabetes and mad cow disease.35
Stem cell therapies are in early phases of development as possible viable solutions for replacement of neurons, disease modeling, and drug development. Restoration of lost neurons and ineffective microglial cells via transplant or in situ stem cell self-renewal and differentiation may offer an effective addition to current AD treatments.
Despite the excitement about cell replacement therapy in AD, challenges do remain. Transplantation data suggests that genetic and epigenetic backgrounds of donor cells are extremely important, so donor-to-donor variation of stem cells must be considered in relationship to propensity for disease development. In addition, transplantation of genetic defects that cause biochemical symptoms of AD must be corrected in donor cells before successful transplantation can occur.36, 37
Researchers are investigating the mechanism of clearance of Aß from the brain across the blood-brain barrier (BBB) as another possible target for therapeutic intervention. The primary receptors for passage of Aß across the BBB are lipoprotein receptor-related protein 1 (LRP1) and receptor for advanced glycation end products (RAGE). A soluble form of the LRP1 molecule sequesters the majority of amyloid peptides in the brain and reduces the plasma levels of the protein. However, in AD the function of the LRP1 molecule is disrupted, leading to abnormally high levels of amyloid in the brain. The other transport molecule, RAGE, when bound to the soluble form of Aß, appears to malfunction and facilitates amyloid passage across the BBB from the peripheral circulation into the brain and acts to promote endothelial inflammation and decreased blood flow. Inhibitors that block RAGE and Aß interaction are plausible targets for intervention.38
Insurance Industry Implications
Dementia is an extremely slow-moving disease with a very long preclinical stage – 15 to 25 years, according to some studies. Biochemical changes occur during this period without outward symptoms. Age is the most important risk factor in the development of dementia, and the presence of vascular risk factors such as smoking, diabetes, hypertension, sleep disorders (particularly obstructive sleep apnea), and atherosclerotic disease, both in the brain and in peripheral arteries, all increase the risk for later-life cognitive impairment. In addition, brain trauma, coronary artery bypass surgery, silent stroke seen on brain imaging studies, and medications such as benzodiazepines and anticholinergics (which treat disorders as diverse as asthma, incontinence, and Parkinson's disease) have been associated with increased dementia risk.39, 40, 41
Applicant mortality assessments should include evaluation of the presence and severity of risk factors for future AD, as well as family history. Older-age questionnaires that focus on subtle changes in cognition or memory function, mental status evaluation, brain imaging, and medical records can all help insurance underwriters develop a history for possible impaired cognition. Work and education history information can also be used to develop baseline cognition function profiles. Independence measured by performance of instrumental activities of daily living, as well as ability to manage finances and use technology such as e-mail, mobile phone, and the internet, should be included in cognitive screenings.
Use of social services may signal a loss of ability to manage instrumental activities of daily living, particularly when the use of in-home social or support services are initiated. However, education, physical activity, and social engagement may offset the negative influence of the aforementioned factors.
Corroboration of the facts by a family member or close friend would be optimal to verify the information acquired through the interview process. Any red flags should warrant additional investigation.
Normal aging manifests as slowed memory and learning acquisition that does not interfere with function in the community. Older-age underwriting will always be challenging due to the heterogeneous nature of the aging process. Biomarkers will continue to evolve and may become more commonly utilized in the diagnostic process, but today, brain imaging and cognitive screening tests are the methods used to diagnose dementia.
AD remains a puzzle that medical science has yet to understand fully. The disease presents many concerns and challenges, particularly since the global population is aging and rates of occurrence for dementia are likely to increase rapidly over the next 30 years. Potential etiologies for the disease are diverse and are the focus of ongoing research. Trials of pharmaceuticals to prevent and treat disease have been unsuccessful to date. Clearly, new avenues for research and development will have to be examined to address this complex disease.
Alzheimer's Association. 2018 Alzheimer's disease facts and figures. Alzheimer's Dement 2018. https:// www.alz.org/media/HomeOffice/Facts%20and%20 Figures/facts-and-figures.pdf
Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16; 90(3):126-35. https://www.ncbi.nlm.nih.govpubmed/29282327
Alzheimer's Disease International. The WORLD Alzheimer Report 2015. https://www.alz.co.uk/ research/statistics
Hebert LE, Weuve J, Scherr PA, et al. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013 May 7; 80 (19):1778-83. https://www.ncbi.nlm.nih.gov/pubmed/23390181
Chêne G, Beiser A, Au R, et al. Gender and incidence of dementia in the Framingham Heart Study from mid- adult life. Alzheimer's Dement. 2015 Mar; 11(3): 310-20. https://www.ncbi.nlm.nih.gov/pubmed/24418058
Brodaty H, Seeher K, Gibson L. Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr. 2012 Jul; 24(7): 1034-45. https://www. ncbi.nlm.nih.gov/pubmed/22325331
Rabinovici G. Article 1: Late-onset Alzheimer Disease. Contiuum (Minneap Minn) 2019 Feb; 25(1): 14-33. https://journals.lww.com/continuum/ Fulltext/2019/02000/Key_Points_for_Issue.21.aspx
Thal DR, Rub U, Orantes M, et al. Phases of A beta- deposition in the human brain and its relevance for the development of AD. Neurology. 2002 Jun 25; 58(12): 1791-800. https://www.ncbi.nlm.nih.gov/ pubmed/12084879
Ossenkoppele R, Jansen WJ, Rabinovici GD, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015 May 19; 313 (19): 1939-49. https://www.ncbi.nlm.nih.gov/ pubmed/25988463
Nelson PT, Alafuzoff I, Bigio EH, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012 May; 71(5): 362-81. https://www.ncbi.nlm.nih.gov/pubmed/22487856
Schneider JA, Arvanitakis Z, Leurgans SE, et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neuro. 2009 Aug; 66(2): 200-8. https://www.ncbi.nlm.nih.gov/ pubmed/19743450
Kawas CH, Kim RC, Sonnen JA, et al. Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study. Neurology. 2015 Aug 11; 85(6): 535-42. https://www.ncbi.nlm.nih.gov/pubmed/26180144
Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000 Mar-Apr; 21(2): 153-60. https://www.ncbi. nlm.nih.gov/pubmed/10867200
Breteler MM. Vascular involvement in cognitive decline and dementia: epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Annals of the New York Academy of Sciences. 2000 Apr; 903: 457-65. https://www.ncbi.nlm.nih.gov/ pubmed/10818538
Ott A, Stolk RP, Hofman A, et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology. 1999; 53: 1907-9. https://www.ncbi.nlm. nih.gov/pubmed/10599761
Ott A, Breteler MM, deBruyne MC, et al. Atrial fibrillation and dementia in a population-based study: The Rotterdam Study. Stroke. 1997 Feb; 28(2): 316-21. https://www.ncbi.nlm.nih.gov/pubmed/9040682
Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population- based cohort study: the Rotterdam Study. Lancet. 1998; 351(9119): 1840-3. https://www.ncbi.nlm.nih. gov/pubmed/9652667
Van Duijn CM, Havekes LM, van Broeckhoven C, et al. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ. 1995 Mar 11; 310(6980): 627-31. https://www.ncbi.nlm.nih.gov/pubmed/7703749
Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997 Jan 18: 349(9046): 151-4. https://www.ncbi.nlm. nih.gov/pubmed/9111537
Petrovitch H, White LR, Izmirillian G, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia Aging Study. Neurobiol Aging. 2000 Jan-Feb; 21(1): 57-62. https://www.ncbi.nlm.nih.gov/ pubmed/10794849
Kivipelto M, Helkala EL, Hanninen T, et al.Midlife vascular risk factors and late-life cognitive impairment: a population-based study. Neurology. 2001 Jun 26; 56(12): 1683-9. https://www.ncbi.nlm. nih.gov/pubmed/11425934
Lourida I, Hannon E, Littlejohns TJ, et al. Association of Lifestyle and Genetic Risk With Incidence of Dementia. JAMA. 2019 Jul 14; 322(5): 430-7. https://jamanetwork.com/journals/jama/article- abstract/2738355
Clayton KA, Van Enoo AA, Ikezu T. Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy. Front Neurosci. 2017 Dec 12; 11: 680. https://www.ncbi.nlm.nih.gov/pubmed/29311768
Keren-Shaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer's disease. Cell. 2017 Jun 15. 169(7), 1276-90. https://www.ncbi.nlm.nih.gov/ pubmed/28602351
Norins LC. It's Time to Find the "Alzheimer's Germ." Alzgerm.org. 2018 Jan 15. https://alzgerm.org/ whitepaper/
Loeb MB, Molloy DW, Smieja M, et al. A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. J AM Geriatric Soc. 2004 Mar; 52(3): 381-7. https://www.ncbi.nlm.nih.gov/ pubmed/14962152
Weller N. Alzheimer's Disease is a 'Double-Prion Disorder,' Study Shows. (Press Release) UCSF. 2019 1 May. https://www.ucsf.edu/news/2019/05/414326/ alzheimers-disease-double-prion-disorder-study- shows
Aoyagi A, Condello C, Stöhr J, et al. Aß and tau prion- like activities decline with longevity in the Alzheimer's disease human brain. Science Translational Medicine. 2019 May 1; 11(490). https://stm.sciencemag.org/ content/11/490/eaat8462
Readhead B, Haure-Mirande JV, Funk CC, et al. Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018 Jul 11; 99(1): 64-82. https://www.ncbi.nlm.nih. gov/pubmed/29937276
Gauthier S, Cummings J, Ballard C, et al. Management of behavioral problems in Alzheimer's disease. IntPsychogeriatric. 2010 May; 22(3): 346-72. https://www.ncbi.nlm.nih.gov/pubmed/20096151
Burke M. Why Alzheimer's Drugs Keep Failing. Scientific American. 2014 Jul 14. https://www. scientificamerican.com/article/why-alzheimer-s-drugs- keep-failing
Thal LJ, Kantarci K, Reiman EM, et al. The Role Of Biomarkers in Clinical Trials for Alzheimer Disease. Alz Dis Assoc Disord. 2006 Jan-Mar; 20(1): 6-15. https://www.ncbi.nlm.nih.gov/pubmed/16493230
Counts SE, Lahiri DK. Overview of Immunotherapy in Alzheimer's Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD. Curr Alzheimer Res. 2014; 11(7): 623-5. https://www.ncbi. nlm.nih.gov/pmc/articles/PMC5870835/
Marino Gammazza A, Bavisotto CC, Barone R, et al. Alzheimer's Disease and Molecular Chaperones: Current Knowledge and the Future of Chaperonotherapy. Curr Pharm Des. 2016: 22(26); 4040-9. https://www.ncbi.nlm.nih.gov/ pubmed/27189602
Marzban L, Park K, Verchere CB. Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol. 2003 Apr; 38(4): 347-51. https://www.ncbi.nlm.nih.gov/ pubmed/12670620
Lee JH, Oh IH, Lim HK. Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease. Psychiatry Investig. 2016 Nov; 13(6): 583-9. https:// www.ncbi.nlm.nih.gov/pubmed/27909447
Yagi T, Ito D, Okada Y, et al. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet. 2011 Dec 1; 20(23): 4530-9. https://www.ncbi.nlm.nih.gov/pubmed/21900357
Deane R, Bell RD, Sagare A, et al. Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets. 2009 Mar; 8(1): 16-30. https://www.ncbi.nlm.nih.gov/pubmed/19275634
Keene CD, Montine TJ, Kuller LH. Epidemiology, pathology, and pathogenesis of Alzheimer disease. UpToDate. 2019 Jul. https://www.uptodate.com/ contents/epidemiology-pathology-and-pathogenesis- of-alzheimer-disease
Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001 Feb 8; 344: 395-402. https://www.nejm.org/doi/ full/10.1056/NEJM200102083440601
Yao H, Fujishima M. Cerebral blood flow and metabolism in silent brain infarction and related cerebrovascular disorders. Ann Med. 2001 Mar; 33(2): 98-102. https://www.ncbi.nlm.nih.gov/ pubmed/11327121
© 2019, Reinsurance Group of America, Incorporated. All rights reserved. No part of this publication may be reproduced in any form without the prior permission of the publisher. For requests to reproduce in part or entirely, please contact: publications@rgare.com. RGA has made all reasonable efforts to ensure that the information provided in this publication is accurate at the time of inclusion and accepts no liability for any inaccuracies or omissions. None of the information or opinions contained in this publication should be construed as constituting medical advice.
Download "ReFlections Vol. 48, Sept. 2019"
Dr. Lisa Duckett
DBIM
Vice President and
U.S. Mortality Markets
Alzheimer's disease (AD) was first described over a century ago, but it may be time to re-evaluate this devastating disease, look at possible etiologies and focus research in different areas. RGA's Dr. Lisa Duckett shares current research into prevention and treatment.
Asia's Senior Markets
Insuring Asia's changing senior markets
Bridging the Senior Services Gap: Wellness and Insurance
New Thoughts on Insuring Long Term Care
Report on the Survey of Older Age Mortality and Other Assumptions
Pseudodementia: An Insurable Condition?
Alzheimer's: An Update on an Old Disease
Living to 100: The Insurance Perspective on Aging
Age Reductions in Group Life Insurance
aging asia insurance
alzheimer life insurance
cognition impairment insurance
dementia insurance
Lisa Duckett
long term care product trend
LTC trends
older age morality life insurance
older age morbidity insurance
senior market insurance


We finally decided to buy three trees for our front yard. Here is one of them changing the view from my office window.
Very pretty - is that a type of Maple?
yes, sugar or October or something like that, maybe blaze.


How to make an prayer before starting work in the office on mondays.
Question: Can you please help compose an opening Monday prayer to start work in a government office. Thank you.
Comments for How to make an prayer before starting work in the office on mondays.
Thank you for the beautiful pray.. Can I use it for a different day?
An essay or research paper is the most important task for students during their final year of education at university level and is an indicator of their true ability for the students and research students.
We should all start our working before prayers. Nice message in the article, glad to be here and part of the article.
This is quite an very good thought and it will help every individual.
I bring Your presence with me.
and Your perfect order into this office.
will be spoken, thought, decided, and done within these walls.
I commit to using them responsibly in Your honor.
Give me a fresh supply of strength to do my job.
It is neer occured to me that praying before work can make the working day more inspiring. In www.Essay-Wizard.com you can find many essays which discuss how prayer helps us in life.
If you are searching for online websites that are offering free services then you need to take care of your own articles because most of them are fake but best writing service review would help you to read more about pros and cons of all websites which are offering essay related material to online users for free.
And I appreciate your decision to include a prayer for the starting of the work in Monday. I am going to try this in my office. Actually, our office does not have any prayers before starting the work.Beverly Diamonds ReviewsThat example of the prayer was awesome.
"Lord Jesus, as I enter this work place, I bring your presence with me. I speak your peace, your grace and your perfect order into the atmosphere of this office. I acknowledge your Lordship over all that will be spoken, thought, decided and accomplished within these walls. Lord Jesus, I thank you for the gifts you have deposited in me. I do not take them lightly but commit to using them responsibly and well. Give me a fresh supply of truth and beauty on which to draw as I do my job. Anoint my creativity, my ideas, my energy, so that even my smallest task might bring your honour. Lord when I am confused guide me. When I am weary, energize me. Lord, when I am burned out infuse me with the light of the Holy Spirit. May the work that i do and the way I do it bring hope, life and courage to all that I come in contact with today. And oh Lord, even in the most stressful moments, may I rest in you. In the mighty name that is above all names, in the matchless name of my Lord and Savior JESUS CHRIST...Amen.
Abbba Father, purify my boss and colleagues even those who do not like me in the Precious blood of Jesus and fill them with Holy Spirit".


Open to see the markets and learn about our new Orange Juice program!
Eggs and butter adjusting down while cheese is still up.
Cheese still aggressive, butter bounced back and eggs dropped!
Currently, there is a worldwide shortage of squid due to rising ocean water temperatures and the prices are now the highest we have seen in 10 years.
Cheese up on average, butter down, eggs stable.